Examples of using Study population in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
ITP study population.
Ispitivana populacija s ITP-om.Immunogenicity was assessed in a subset(n=182) of the study population.
The mean age of the study population was 37.9 years.
Prosječna dob bolesnika ispitivane populacije bila je 37, 9 godina.The study population was predominantly female(91%) and white(94%).
Populaciju u ispitivanju činile su pretežno žene(91%) i bijelci(94%).Safety and tolerability was evaluated in the entire study population.
Sigurnost primjene i podnošljivost ocjenjivani su na cijeloj populaciji u ispitivanju.
Table 5: Study population from study CO-US-104-0288 iPrEx.
Tablica 5: Ispitivana populacija u ispitivanju CO-US-104-0288 iPrEx.Patients with common EGFR mutations accounted for 89% of the study population.
Table 8: Study population from study CO-US-104-0380 Partners PrEP.
Tablica 8: Ispitivana populacija u ispitivanju CO-US-104-0380 Partners PrEP.Results from the overall UC-II study population are shown in Table 21.
HCV study population in combination with anti-viral interferon and ribavirin therapy.
Ispitivana populacija s HCV-om u kombinaciji s antivirusnim liječenjem interferonom i ribavirinom.The protocol of study GAO4753g defined patients with iNHL including FL as the study population.
Protokol ispitivanja GAO4753g definirao je kao ispitivanu populaciju bolesnike s iNHL-om, uključujući FL.The study population had an average age of 62 years; the average duration of diabetes was 9.5 years.
Prosječna dob ispitivane populacije bila je 62 godine; prosječno trajanje šećerne bolesti bilo je 9, 5 godina.Represents the highest frequency observed either in the healthy adult orhealthy older study population.
Predstavlja najveću učestalost zabilježenu 
The measure is relevant to the study population;• the measure is relevant to the experts in the subject;
Da mjerenje bude relevantno za istraživanu populaciju;• da mjerenje bude relevantno stručnjacima na tom području;The Receiver Operating Characteristic(ROC) curve analysis of Fenyö-Lindberg score showed that the best single cut-off value for discriminating acute appendicitis in the study population was -15.
Usporedba krivulja ROC za Fenyö-Lindbergov zbir pokazala je da je najbolja pojedinačna granična vrijednost u proučavanoj populaciji u svrhu diskriminacije akutne upale crvuljka-15.The effect on race could not be analysed because the study population was predominantly Caucasian 88.
Budući da su bolesnici bijele rase činili najveći dio ispitivane populacije(88%), nije se mogao analizirati učinak rase.The study population consisted of 1,892 patients randomised by means of an interactive voice response system.
Ispitivana populacija sastojala se od 1892 bolesnika randomiziranih putem sustava interaktivnog glasovnog odgovora.Approximately half of the study population had at least two of the cardiovascular history entry criteria.
Približno polovica ispitivane populacije imala je najmanje dva kardiovaskularna kriterija za uključenje u ispitivanje.The study population included 2,004 patients≥ 75 years of age and 3,324 patients with renal impairment.
Ispitivana populacija uključivala je 2004 bolesnika u dobi od ≥ 75 godina te 3324 bolesnika s oštećenjem funkcije bubrega.Approximately half of the study population had at least two of the cardiovascular history entry criteria.
Približno je polovica ispitivane populacije zadovoljila najmanje dva kriterija uključenja u pogledu kardiovaskularne bolesti u anamnezi.The study population included 2,004 patients≥ 75 years of age and 3,324 patients with renal impairment eGFR< 60 mL/min/1.73 m2.
Ispitivana populacija uključivala je 2004 bolesnika u dobi od ≥ 75 godina te 3324 bolesnika s oštećenjem funkcije bubrega eGFR< 60 ml/min/1, 73 m2.Idiopathic or heritable PAH was the most common aetiology in the study population(56%), followed by PAH due to connective tissue disorders(37%), PAH associated with drugs and toxins(3%), corrected simple congenital heart disease(2%), and HIV 2.
Idiopatski ili nasljedni PAH bio je najčešća etiologija u ispitivanoj populaciji(56%), a nakon njega su slijedili PAH povezan s bolešću vezivnog tkiva(37%), PAH povezan s lijekovima i toksinima(3%), korigirana jednostavna prirođena srčana bolest(2%) i HIV 2.The study population was 82% male, 39% Caucasian, and 37% Asian, with a mean age of 49 years; 89% of patients had HBeAg-negative disease at the time of transplant.
U ispitnoj populaciji bilo je 82% muškaraca, 39% bijelaca i 37% azijata, prosječne dobi od 49 godina; 89% bolesnika imalo je HBeAg-negativnu bolest Idiopathic or heritable PAH was the most common aetiology in the study population(58%) followed by PAH due to connective tissue disorders(29%), PAH associated with simple corrected congenital heart disease(10%), and PAH associated with other aetiologies drugs and toxins[2%] and HIV 1.
U ispitivanoj populaciji etiološki je najčešći bio idiopatski ili nasljedni PAH(58%), zatim PAH zbog bolesti vezivnog tkiva(29%) PAH povezan s korigiranom jednostavnom prirođenom srčanom manom(10%) te PAH povezan s drugom etiologijom lijekovi i toksini[2%] i HIV 1.The study population comprised patients with technically unresectable disease, patients with low probability of surgical cure and patients aiming at organ preservation.
Studijska populacija uključivala je bolesnike s tehnički neoperabilnom bolešću, bolesnike s malom vjerojatnošću kirurškog izliječenja i bolesnike kod kojih se težilo očuvanju organa.Idiopathic or heritable PAH was the most common aetiology in the study population(57%), followed by PAH due to connective tissue disorders(31%), PAH associated with corrected simple congenital heart disease(8%), and PAH associated with other aetiologies drugs and toxins[3%] and HIV 1.
Idiopatski ili nasljedni PAH bio je najčešća etiologija u populaciji ispitivanja(57%), nakon čega je slijedio PAH zbog bolesti vezivnog tkiva(31%), PAH povezan s korigiranom jednostavnom srčanom manom(8%) i PAH povezan s drugim etiologijama lijekovi i toksini[3%] i HIV 1.The study population consisted of approximately 48% antimuscarinic treatment naïve patients as well as approximately 52% patients previously treated with antimuscarinic medication.
Ispitivana populacija sastojala se od oko 48% bolesnika koji prethodno nisu primali antimuskarinsku terapiju, te oko 52% bolesnika koji su ranije liječeni s antimuskarinskim lijekovima.Materials and Methods: The study population consisted of 728 out-patients, 340 males and 388 females aged 40 to 70 years.
Materijal i metode: Analizirana populacija sastojala se od 728 vanjskih pacijenata- 340 muškaraca i 388 Å3⁄4ena u dobi od 40 do 70 godina.The study population included those≥ 65 years(n=8561) and≥ 75 years(n=2330), with normal or mild renal impairment(n=13,916) as well as moderate(n=2240) or severe(n=336) renal impairment.
Ispitivana populacija uključivala je osobe u dobi od ≥ 65 godina(n=8561) i ≥ 75 godina(n=2330) s normalnom ili blago oštećenom bubrežnom funkcijom(n=13 916), kao i one s umjereno(n=2240) ili teško(n=336) oštećenom bubrežnom funkcijom.Efficacy for patients identified within the Phase 1/2 study population who failed either imatinib alone or imatinib in addition to one or both second-generation TKIs(dasatinib and nilotinib) and for whom, based on the presence of co-morbidities, a history of TKI intolerance, or a BCR-ABL resistance mutation, the remaining approved TKI(s) are not considered appropriate treatment options was reviewed.
Razmotrena je djelotvornost u bolesnika identificiranih u ispitivanoj populaciji u fazi 1/ 2 u kojih nije uspjelo liječenje samim imatinibom ili imatinibom kojem je uslijedio jedan ili oba TKI-a druge generacije( dasatinib i nilotinib) i u kojih se ostali( jedan ili više) odobreni TKI ne smatraju prikladnim izborom liječenja na temelju prisutnih komorbiditeta, anamneze nepodnošenja TKI-a ili rezistencije Bcr-Abl-a zbog mutacije.
